v1
Abstract 3434: APVO442 is a distinct PSMA x CD3 targeted bispecific candidate designed to optimize T cell fitness and distribution to solid tumors
Identifier:nobleid.org/w1/20260515/CF2B76D8
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CF2B76D8)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →